Expanded Partnership Demonstrates Value of Technology-Enabled Services and Autonomous Pharmacy Vision
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Mar. 3, 2021--
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced continued growth for the Company’s cloud-based solutions and technology-enabled services as it continues to drive market adoption of the Autonomous Pharmacy vision.
Omnicell is committed to transforming the pharmacy care delivery model through the Autonomous Pharmacy, a combination of hardware, software, and services that enables providers to improve quality, reduce costs, and increase human efficiencies. The Christ Hospital Health Network, based in Cincinnati, Ohio, an existing Omnicell partner, is moving toward the Autonomous Pharmacy with the adoption of the Company’s Central Pharmacy Dispensing Service which will automate critical workflows in Central Pharmacy, supported by expertly trained technicians to optimize the technology and contribute to overall operational efficiency.
Manual and disjointed processes in Central Pharmacy are a leading contributor to safety and operational challenges, with a rate of one error per every 200 dispenses.1 Not only are these manual processes leading to errors, but they are also causing pharmacists to spend 75 percent of their time on non-clinical activities,2 which has rippling effects on patient care, employee satisfaction, and turnover.
Omnicell’s Central Pharmacy Dispensing Service combines advanced robotic dispensing technology, expertly trained dedicated technicians, best practice and benchmarking tools, change management expertise, and ongoing clinical optimization to maximize value and support clinical, operational, and financial outcomes. The Christ Hospital Health Network is one of the latest health systems to adopt this comprehensive solution to help enhance patient safety, reduce medication waste, and enable the reallocation of high value clinical resources.
“Automation offers many benefits, including increased safety, efficiency and cost savings, but automation on its own is not enough,” said Justin M. Gamble, PharmD, Network Director of Pharmacy at The Christ Hospital Health Network. “Through comprehensive operational service models like Central Pharmacy Dispensing Service, we are able to optimize and maximize the benefit of automation technology, allowing our staff to shift focus from logistical tasks to play a more active role in patient care initiatives.”
Nearly 50 percent of Top 300 U.S. health systems3 are partnering with Omnicell on the journey to the Autonomous Pharmacy, a roadmap to develop a zero-error, fully automated medication management infrastructure. Omnicell is committed to transforming the pharmacy care delivery model through the Autonomous Pharmacy, a combination of hardware, software, and technology-enabled services that enables providers to improve quality, reduce costs, and increase human efficiencies. Through Omnicell’s industry-leading medication management platform and portfolio of technology-enabled services, health systems and retail pharmacies are realizing how connected technology and intelligence can help solve for the most pressing challenges in medication management.
“Omnicell is delivering the technology and services to address the gaps and challenges across an increasingly complex and critical pharmacy supply chain,” said Scott Seidelmann, executive vice president and chief commercial officer at Omnicell. “The growth in adoption of solutions like our Central Pharmacy Dispensing Service demonstrates that the market recognizes the value of the Autonomous Pharmacy vision to improve efficiencies across the continuum of care, driving better outcomes and performance.”
About The Christ Hospital Health Network
The Christ Hospital Health Network is an acute care hospital located in Cincinnati, OH with a remote hospital location in Liberty Township, five ambulatory outpatient centers and dozens of offices conveniently located throughout the region. More than 1,300 talented physicians and more than 6,000 dedicated team members support the Network. Its mission is to improve the health of the community and to create patient value by providing exceptional outcomes and the finest experiences, all in an affordable way. The Network has been recognized by U.S. News & World Report as the #1 hospital in the Cincinnati Region and awarded Healthgrades “America’s 50 Best Hospitals” for being in the top 1% in the nation for providing the highest clinical quality year over year. It is also a Press Ganey Guardian of Excellence Award recipient, which recognizes top-performing healthcare organizations that achieve the 95th percentile or above of performance in patient experience. The Christ Hospital is among a select number of hospitals in the nation to be awarded Magnet® recognition for nursing excellence.
Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 7,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. To learn more, visit www.omnicell.com.
1Ann Intern Med. 2006;145(6):426-424.
2Schneider PJ, et al. American Journal of Health-System Pharmacy. 2019;76(15):1127-1141.
3As defined by Definitive Healthcare
View source version on businesswire.com: https://www.businesswire.com/news/home/20210303005260/en/
Source: Omnicell, Inc.